Sequence-specific 1H NMR assignments, secondary structure, and location of the calcium binding site in the first epidermal growth factor like domain of blood coagulation factor IX.

Factor IX is a blood clotting protein that contains three regions, including a gamma-carboxyglutamic acid (Gla) domain, two tandemly connected epidermal growth factor like (EGF-like) domains, and a serine protease region. The protein exhibits a high-affinity calcium binding site in the first EGF-like domain, in addition to calcium binding in the Gla domain. The first EGF-like domain, factor IX (45-87), has been synthesized. Sequence-specific resonance assignment of the peptide has been made by using 2D NMR techniques, and its secondary structure has been determined. The protein is found to have two antiparallel beta-sheets, and preliminary distance geometry calculations indicate that the protein has two domains, separated by Trp28, with the overall structure being similar to that of EGF. An NMR investigation of the calcium-bound first EGF-like domain indicates the presence and location of a calcium binding site involving residues on both strands of one of the beta-sheets as well as the N-terminal region of the peptide. These results suggest that calcium binding in the first EGF-like domain could induce long-range (possibly interdomain) conformational changes in factor IX, rather than causing structural alterations in the EGF-like domain itself.

[1]  N. Go,et al.  Tertiary structure of mouse epidermal growth factor determined by two-dimensional 1H NMR. , 1988, Journal of biochemistry.

[2]  J. Stenflo,et al.  sup 1 H NMR assignment and secondary structure of the Ca sup 2+ -free form of the amino-terminal epidermal growth factor like domain in coagulation factor X , 1990 .

[3]  S. Linse,et al.  Calcium binding to the epidermal growth factor homology region of bovine protein C. , 1988, The Journal of biological chemistry.

[4]  D. Kohda,et al.  Polypeptide chain fold of human transforming growth factor alpha analogous to those of mouse and human epidermal growth factors as studied by two-dimensional 1H NMR. , 1989, Biochemistry.

[5]  H. Scheraga,et al.  Solution structure of murine epidermal growth factor: determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Fernlund,et al.  Beta-hydroxyaspartic acid in vitamin K-dependent proteins. , 1983, The Journal of biological chemistry.

[7]  I. Campbell,et al.  A high-resolution 1H-NMR study of human transforming growth factor alpha. Structure and pH-dependent conformational interconversion. , 1989, European journal of biochemistry.

[8]  C. Esmon,et al.  Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid. , 1984, The Journal of biological chemistry.

[9]  An SN2 deprotection of synthetic peptides with a low concentration of hydrofluoric acid in dimethyl sulfide: evidence and application in peptide synthesis , 1983 .

[10]  A. Pardi,et al.  Two-dimensional NMR studies of the antimicrobial peptide NP-5. , 1987, Biochemistry.

[11]  T. Creighton.  Proteins: Structures and Molecular Properties , 1986 .

[12]  S. Cohen,et al.  The primary structure of epidermal growth factor. , 1972, The Journal of biological chemistry.

[13]  A. Pardi,et al.  Solution structures of the rabbit neutrophil defensin NP-5. , 1988, Journal of molecular biology.

[14]  W. Kisiel,et al.  Protein structural requirements and properties of membrane binding by gamma-carboxyglutamic acid-containing plasma proteins and peptides. , 1989, The Journal of biological chemistry.

[15]  J. Tam,et al.  Calcium binding and putative activity of the epidermal growth factor domain of blood coagulation factor IX. , 1989, Biochemical and biophysical research communications.

[16]  D. Monroe,et al.  Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain. , 1990, The Journal of biological chemistry.

[17]  Shu-Wha Lin,et al.  Factor IX New London: substitution of proline for glutamine at position 50 causes severe hemophilia B , 1990 .

[18]  J. Ware,et al.  Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B. , 1987, Blood.

[19]  S. Brown,et al.  Solution structures of human transforming growth factor alpha derived from 1H NMR data. , 1990, Biochemistry.

[20]  I. Campbell,et al.  The solution structure of human epidermal growth factor , 1987, Nature.

[21]  S. Linse,et al.  Calcium binding to the isolated beta-hydroxyaspartic acid-containing epidermal growth factor-like domain of bovine factor X. , 1989, The Journal of biological chemistry.

[22]  D. Strickland,et al.  Conformational changes in an epitope localized to the NH2-terminal region of protein C. Evidence for interaction of protein C domains. , 1989, The Journal of biological chemistry.

[23]  B. Furie,et al.  The molecular basis of blood coagulation , 1988, Cell.

[24]  W. Kisiel,et al.  Calcium binding to a human factor IXa derivative lacking γ-carboxyglutamic acid: Evidence for two high-affinity sites that do not involve β-hydroxyaspartic acid , 1985 .